Specifically, the expression levels of GPR6 (P = 0.16), GPR37 (P = 0.51) and ADGRL4 (P = 0.51) are not associated with the prognosis of AML patients (Fig. 1C). Here, GPR6 is linked to acute myeloid leukemia.